A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia
Completed · Phase 4 · Has a placebo group
Conditions studied: Post-Menopausal Osteopenia
In brief
This 2 arm study will evaluate the efficacy and safety of oral Bonviva 150mg once monthly compared with placebo in post-menopausal women with osteopenia. Patients will be randomized to receive either Bonviva 150mg po monthly, or placebo monthly. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.
Key facts
- Study ID
- NCT00129623
- Run by
- Hoffmann-La Roche
- People needed
- 160
- Starts
- 2005-12-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2016-01-11
Who can join
Age: 45 and older, up to 60. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- women 45-60 years of age;
- post-menopausal;
- ambulatory.
You may not qualify if…
- vertebral fracture (except traumatic fracture such as in a motor vehicle accident);
- low-trauma osteoporotic fracture in any other bone;
- breast cancer diagnosed within last 20 years;
- other malignancy diagnosed within last 10 years, except successfully resected basal cell cancer;
- treatment with any bisphosphonate within last 2 years;
- treatment with other drugs affecting bone metabolism within last 6 months.
Where it is running
- Study site — Lakewood, Colorado, United States
- Study site — Stuart, Florida, United States
- Study site — Bethesda, Maryland, United States
- Study site — Detroit, Michigan, United States
- Study site — St Louis, Missouri, United States
- Study site — Omaha, Nebraska, United States
- Study site — Albuquerque, New Mexico, United States
- Study site — Cincinnati, Ohio, United States
- Study site — Portland, Oregon, United States
- Study site — Amarillo, Texas, United States
- Study site — Norfolk, Virginia, United States
- Study site — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.